Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein

The EMBO Journal
J RothA J Levine

Abstract

The hdm2 gene is overexpressed in a variety of human tumors. Its gene product localizes predominantly to the nucleus, where it acts as an inhibitor of the p53 tumor suppressor gene product. It is shown here that the hdm2 oncoprotein constantly shuttles between the nucleus and the cytoplasm. Shuttling of hdm2 does not depend on its interaction with p53. Nuclear export of hdm2 is mediated by a signal sequence similar to the nuclear export signal of the rev protein from human immunodeficiency virus and other lentiviruses. Mutation of this signal sequence abolishes detectable nucleo-cytoplasmic shuttling. When fused to a carrier protein, the hdm2 signal sequence can mediate nuclear export after intranuclear microinjection into HeLa cells. The export of hdm2 can be blocked by a competitive inhibitor of rev export, arguing that the export pathways for hdm2 and rev are either overlapping or identical. Inhibition of its export modifies the ability of hdm2 to block p53-mediated transcriptional activation, and hdm2's export function is required to accelerate the degradation of p53. Thus the rev nuclear export pathway may be used to regulate an oncogene product's activity and modulate cellular growth.

References

Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·U M MollA J Levine
Feb 20, 1992·Nature·S Piñol-Roma, G Dreyfuss
Mar 1, 1994·The Journal of Cell Biology·A JarmolowskiI W Mattaj
Apr 21, 1995·Cell·E Izaurralde, I W Mattaj
Aug 1, 1995·FEBS Letters·G Simos, E C Hurt
Sep 15, 1995·The EMBO Journal·J MosnerW Deppert
Aug 1, 1995·Proceedings of the National Academy of Sciences of the United States of America·S LiangA M Tartakoff
May 9, 1995·Proceedings of the National Academy of Sciences of the United States of America·U M MollG Riou
Jul 1, 1993·Genes & Development·X WuA J Levine
Apr 2, 1996·Proceedings of the National Academy of Sciences of the United States of America·R A FridellB R Cullen
May 10, 1996·The Journal of Biological Chemistry·W M Michael, G Dreyfuss
Feb 1, 1996·Current Biology : CB·M S Moore
Oct 1, 1996·Proceedings of the National Academy of Sciences of the United States of America·C DietrichR J Wieser
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·M MooreT Shenk
Dec 24, 1996·Proceedings of the National Academy of Sciences of the United States of America·K K Walker, A J Levine
May 15, 1997·Nature·Y HauptM Oren
May 15, 1997·Nature·M H KubbutatK H Vousden

❮ Previous
Next ❯

Citations

May 15, 2001·International Journal of Cancer. Journal International Du Cancer·E TamboriniS Pilotti
Aug 17, 2010·Cellular and Molecular Life Sciences : CMLS·Carlos S BussoTadahide Izumi
Sep 17, 2009·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Rosario AmatoNicola Perrotti
Jun 1, 2005·Biochimica Et Biophysica Acta·Leena Latonen, Marikki Laiho
Jun 2, 2005·Cancer Letters·Andrew SlackJason M Shohet
Jan 28, 2004·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Aurora O'Brate, Paraskevi Giannakakou
Jun 15, 2005·Journal of Molecular Biology·Stanislava UhrinovaPaul N Barlow
Jan 18, 2003·Experimental Cell Research·Megan Fabbro, Beric R Henderson
Mar 5, 1999·Brain Research. Molecular Brain Research·D UbertiV Rotter
Jun 6, 2003·Advanced Drug Delivery Reviews·Joshua Z Gasiorowski, David A Dean
Jun 17, 2000·Progress in Neurobiology·K J BanasiakG G Haddad
Oct 31, 2002·Cancer Letters·V Peter Collins
Sep 1, 2000·Biochimica Et Biophysica Acta·J K Hood, P A Silver
Mar 12, 2003·Toxicology Letters·Bernhard Brüne, Nicole Schneiderhan
May 10, 2000·Current Opinion in Cell Biology·A Komeili, E K O'Shea
May 10, 2000·Current Opinion in Cell Biology·R Visintin, A Amon
May 10, 2001·Current Opinion in Cell Biology·K M RyanK H Vousden
Feb 19, 2000·Current Opinion in Genetics & Development·C J Sherr, J D Weber
Jul 31, 2001·Surgical Oncology·C M HalloranE Costello
Sep 25, 2001·Trends in Cell Biology·C Schwechheimer, X W Deng
Jan 1, 2003·Seminars in Cancer Biology·Dan Michael, Moshe Oren
Jul 29, 1998·Molecular Medicine Today·M H Kubbutat, K H Vousden
Feb 5, 2003·Drug Discovery Today·Tweeny R Kau, Pamela A Silver
Apr 18, 2000·Mutation Research·M S ColmanJ C Barrett
Sep 29, 2001·Nature Immunology·T StanislawskiM Theobald
Nov 4, 2000·The Biochemical Journal·T R HuppK L Ball
Aug 9, 2002·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Shinya H Kimura, Hiroshi Nojima
May 19, 2001·European Journal of Biochemistry·S H Liang, M F Clarke
Oct 29, 2009·The Journal of Biological Chemistry·Tomohiro NishimuraKyoko Tsukiyama-Kohara
May 15, 2007·The Journal of Biological Chemistry·Christopher L BrooksWei Gu
Sep 11, 2008·The Journal of Biological Chemistry·James X DuVincent W Yang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.